• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.

作者信息

Komrokji Rami S, Platzbecker Uwe, Fenaux Pierre, Zeidan Amer M, Garcia-Manero Guillermo, Mufti Ghulam J, Santini Valeria, Díez-Campelo María, Finelli Carlo, Jurcic Joseph G, Greenberg Peter L, Sekeres Mikkael A, DeZern Amy E, Savona Michael R, Shetty Jeevan K, Ito Rodrigo, Zhang George, Ha Xianwei, Backstrom Jay T, Verma Amit

机构信息

Moffitt Cancer Center, Tampa, FL, USA.

Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.

出版信息

Leukemia. 2022 May;36(5):1432-1435. doi: 10.1038/s41375-022-01521-4. Epub 2022 Feb 26.

DOI:10.1038/s41375-022-01521-4
PMID:35220402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9061284/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8590/9061284/d3f79c142aa4/41375_2022_1521_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8590/9061284/e3ce6bfa7c17/41375_2022_1521_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8590/9061284/d3f79c142aa4/41375_2022_1521_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8590/9061284/e3ce6bfa7c17/41375_2022_1521_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8590/9061284/d3f79c142aa4/41375_2022_1521_Fig2_HTML.jpg

相似文献

1
Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.来那度胺用于治疗伴有环形铁粒幼细胞和血小板增多的骨髓增生异常综合征/骨髓增殖性肿瘤。
Leukemia. 2022 May;36(5):1432-1435. doi: 10.1038/s41375-022-01521-4. Epub 2022 Feb 26.
2
New drugs for myeloid neoplasms with ring sideroblasts: Luspatercept vs imetelstat.用于治疗伴有环形铁粒幼细胞的髓系肿瘤的新药：罗特西普与艾美司他。
Am J Hematol. 2021 Jul 1;96(7):761-763. doi: 10.1002/ajh.26197. Epub 2021 May 3.
3
Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.伴有环形铁幼粒细胞和血小板增多的骨髓增生异常/骨髓增殖性肿瘤日本患者的临床特征。
Int J Hematol. 2023 Jul;118(1):47-53. doi: 10.1007/s12185-023-03592-0. Epub 2023 Apr 14.
4
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.卢司帕西普在伴有环形铁粒幼细胞的低危骨髓增生异常综合征患者中的真实世界疗效、安全性及反应预测因素
Am J Hematol. 2023 Aug;98(8):E204-E208. doi: 10.1002/ajh.26960. Epub 2023 May 24.
5
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.芦可替尼治疗低危骨髓增生异常综合征患者的疗效。
N Engl J Med. 2020 Jan 9;382(2):140-151. doi: 10.1056/NEJMoa1908892.
6
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T) and myelodysplastic syndrome with ring sideroblasts (MDS-RS).伴有环形铁粒幼细胞和血小板增多的骨髓增生异常综合征/骨髓增殖性肿瘤（MDS/MPN-RS-T）与伴有环形铁粒幼细胞的骨髓增生异常综合征（MDS-RS）之间的临床、基因组和转录组差异
Am J Hematol. 2021 Jul 1;96(7):E246-E249. doi: 10.1002/ajh.26182. Epub 2021 Apr 24.
7
Real-world experience with luspatercept and predictors of response in myelodysplastic syndromes with ring sideroblasts.卢司帕西普在伴有环形铁粒幼细胞的骨髓增生异常综合征中的真实世界经验及反应预测因素
Am J Hematol. 2022 Jun 1;97(6):E210-E214. doi: 10.1002/ajh.26533. Epub 2022 Mar 29.
8
Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring Sideroblasts.激活素受体II配体陷阱及其在伴有环形铁粒幼细胞的骨髓增生异常综合征中的治疗潜力
Curr Hematol Malig Rep. 2016 Dec;11(6):416-424. doi: 10.1007/s11899-016-0347-9.
9
Clinical analysis and literature review of a case with the myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.伴环形铁幼粒细胞和血小板增多的骨髓增生异常综合征/骨髓增殖性肿瘤的临床分析及文献复习。
Hematology. 2020 Dec;25(1):283-285. doi: 10.1080/16078454.2020.1790840.
10
Lenalidomide therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).来那度胺治疗伴有环形铁粒幼细胞和血小板增多的骨髓增生异常综合征/骨髓增殖性肿瘤（MDS/MPN-RS-T）患者。
Am J Hematol. 2018 Jan;93(1):E27-E30. doi: 10.1002/ajh.24952. Epub 2017 Nov 10.

引用本文的文献

1
Global first-in-class drugs approved in 2023-2024: Breakthroughs and insights.2023 - 2024年获批的全球首创药物：突破与见解。
Innovation (Camb). 2025 Jan 14;6(4):100801. doi: 10.1016/j.xinn.2025.100801. eCollection 2025 Apr 7.
2
Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a practical guide to diagnosis and management.骨髓增生异常综合征/骨髓增殖性肿瘤重叠综合征：诊断与管理实用指南
Leukemia. 2025 Apr 19. doi: 10.1038/s41375-025-02620-8.
3
A novel and apparent missense variant associated with congenital sideroblastic anemia.
一种与先天性铁粒幼细胞贫血相关的新型且明显的错义变异。
Front Pediatr. 2024 Aug 29;12:1411676. doi: 10.3389/fped.2024.1411676. eCollection 2024.
4
Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study.采用芦曲泊帕治疗难治性贫血伴骨髓纤维化：一项多中心的中国研究。
Ann Hematol. 2024 Sep;103(9):3605-3613. doi: 10.1007/s00277-024-05847-0. Epub 2024 Jun 22.
5
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches.接受抗癌治疗患者的贫血：聚焦新型治疗方法。
Front Oncol. 2024 Apr 2;14:1380358. doi: 10.3389/fonc.2024.1380358. eCollection 2024.
6
MicroRNA Expression Patterns Reveal a Role of the TGF-β Family Signaling in AML Chemo-Resistance.微小RNA表达模式揭示了转化生长因子-β家族信号在急性髓系白血病化疗耐药中的作用。
Cancers (Basel). 2023 Oct 21;15(20):5086. doi: 10.3390/cancers15205086.
7
TGF-beta signal transduction: biology, function and therapy for diseases.转化生长因子-β信号转导：生物学、功能及疾病治疗
Mol Biomed. 2022 Dec 19;3(1):45. doi: 10.1186/s43556-022-00109-9.
8
When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms.当骨髓涂片上的环形铁粒幼细胞与骨髓增生异常肿瘤的诊断不符时。
Diagnostics (Basel). 2022 Jul 20;12(7):1752. doi: 10.3390/diagnostics12071752.